Immunosuppression with a combination of PG490-88 and a subtherapeutic dose of FK506 in a canine renal allograft model

Transplantation

Volumn 79, Issue 11, 2005, Pages 1537-1544

  Wang, Ximo ^a   Sun, Hongtao ^a   Chen, Gang ^a   Liu, Weihua ^a   Wise, Yishai ^a   Yung, Chenlin ^a   Sudo, Yuji ^b   Tamura, Kouichi ^b   Garcia, Bertha ^a   Zhong, Robert ^a,c,d,e  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b Fujisawa Pharmaceutical Co L   (Japan)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

^d ROBARTS RESEARCH INSTITUTE   (Canada)

^e LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

Complement; Dog; Kidney; PG 490 88; Rejection; Transplantation

Indexed keywords

COMPLEMENT COMPONENT C4; COMPOUND PG490 88; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; TACROLIMUS; TRIPTERYGIUM WILFORDII EXTRACT; TRIPTOLIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLEEDING; CHINESE HERB; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; CONTROLLED STUDY; DOG; DRUG EFFECT; DRUG EFFICACY; GRAFT REJECTION; GRAFT SURVIVAL; HUMORAL IMMUNITY; IMMUNOGLOBULIN DEPOSITION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME; T LYMPHOCYTE; TRIPTERYGIUM WILFORDII;

ANIMALS; CREATININE; DITERPENES; DOGS; DRUG THERAPY, COMBINATION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MONITORING, PHYSIOLOGIC; SURVIVAL ANALYSIS; TACROLIMUS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TRIPTORELIN;

EID: 20544448725     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000159149.07292.2B     Document Type: Article

References (22)

1. Chen BJ, Liu C, Cui X, et al. Prevention of graft-versus-host disease by a novel immunosuppressant, PG490-88, through inhibition of alloreactive T cell expansion. Transplantation 2000; 70: 1442.
2. Kiviharju TM, Lecane PS, Sellers RG, et al. Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells. Clin Cancer Res 2002; 8: 2666.
3. Leonard CT, Soccal PM, Berry GJ, et al. PG490-88, a derivative of triptolide, attenuates obliterative airway disease in a mouse heterotopic tracheal allograft model. J Heart Lung Transplant 2002; 21: 1314.
4. Krishna G, Liu K, Shigemitsu H, et al. PG490-88, a derivative of triptolide, blocks bleomycin-induced lung fibrosis. Am J Pathol 2001; 158: 997.
5. Wang I, Xu R, Jin R, et al. Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. II. Prolongation of hamster-to-rat cardiac xenograft survival by combination therapy with the PG27 extract and cyclosporine. Transplantation 2000; 70: 456.
6. Wang J, Xu R, Jin R, et al. Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine. Transplantation 2000; 70: 447.
7. Chen BJ, Chen Y, Cui X, et al. Mechanisms of tolerance induced by PG490-88 in a bone marrow transplantation model. Transplantation 2002; 73: 115.
8. Jin MB, Nakayama M, Ogata T, et al. A novel leflunomide derivative, FK778, for immunosuppression after kidney transplantation in dogs. Surgery 2002; 132: 72.
9. Kyles AE, Gregory CR, Griffey SM, et al. Immunosuppression with a combination of the leflunomide analog, FK778, and microemulsified cyclosporine for renal transplantation in mongrel dogs. Transplantation 2003; 75: 1128.
10. Ochiai T, Nagata M, Nakajima K, et al. Studies of the effects of FK506 on renal allografting in the beagle dog. Transplantation 1987; 44: 729.
11. Collins AB, Schneeberger EE, Pascual MA, et al. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 1999; 10: 2208.
12. Crespo M, Lozano M, Sole M, et al. Diagnosis and treatment of acute humoral rejection after kidney transplantation: preliminary experience. Transplant Proc 2003; 35: 1677.
13. Abe M, Sawada T, Horita S, et al. C4d deposition in peritubular capillary and alloantibody in the allografted kidney suffering severe acute rejection. Clin Transplant 2003; 17(Suppl 10): 14.
14. Hong Y, Zhou W, Li K, et al. Triptolide is a potent suppressant of C3, CD40 and B7h expression in activated human proximal tubular epithelial cells. Kidney Int 2002; 62: 1291.
15. Qiu D, Zhao G, Aoki Y, et al. Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation. J Biol Chem 1999; 274: 13443.
16. Liu H, Liu ZH, Chen ZH, et al. Triptolide: a potent inhibitor of NF-kappa B in T-lymphocytes. Acta Pharmacol Sin 2000; 21: 782.
17. Sun H. Synergy of immunosuppression by PG490-88 and FK506 is through downregulation of NF-kB and IL-2. American Journal of Transplantation 2004; (Suppl 8): 442.
18. Sarwal M, Chua MS, Kambham N, et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003; 349: 125.
19. Zhu Y, Suzuki T, Subbotin VM, et al. Prolongation of canine renal allograft survival by combining tacrolimus with antimetabolic agents. Transplant Proc 1997; 29: 308.
20. Chen G. Combination of PG490-88 and low dose FK506 significantly prolonged renal allograft survival in monkeys. American Journal of Transplantation 2004; (Suppl 8): 193.
21. Graves GM, Becht JL, Rawlings CA. Metodopramide reversal of decreased gastrointestinal myoelectric and contractile activity in a model of canine postoperative ileus. Vet Surg 1989; 18: 27.
22. Childs WA, Phillips RB. Experience with intestinal plication and a proposed modification. Ann Surg 1960; 152: 258.